Fortress Biotech, Inc.

NasdaqCM:FBIO Stock Report

Market Cap: US$37.1m

Fortress Biotech Balance Sheet Health

Financial Health criteria checks 0/6

Fortress Biotech has a total shareholder equity of $-3.9M and total debt of $68.4M, which brings its debt-to-equity ratio to -1738.4%. Its total assets and total liabilities are $164.6M and $168.6M respectively.

Key information

-1,738.4%

Debt to equity ratio

US$68.44m

Debt

Interest coverage ration/a
CashUS$83.77m
Equity-US$3.94m
Total liabilitiesUS$168.58m
Total assetsUS$164.65m

Recent financial health updates

Is Fortress Biotech (NASDAQ:FBIO) Using Debt Sensibly?

Jan 11
Is Fortress Biotech (NASDAQ:FBIO) Using Debt Sensibly?

Fortress Biotech (NASDAQ:FBIO) Has Debt But No Earnings; Should You Worry?

Sep 28
Fortress Biotech (NASDAQ:FBIO) Has Debt But No Earnings; Should You Worry?

Does Fortress Biotech (NASDAQ:FBIO) Have A Healthy Balance Sheet?

Jun 04
Does Fortress Biotech (NASDAQ:FBIO) Have A Healthy Balance Sheet?

Recent updates

There's No Escaping Fortress Biotech, Inc.'s (NASDAQ:FBIO) Muted Revenues Despite A 99% Share Price Rise

Dec 29
There's No Escaping Fortress Biotech, Inc.'s (NASDAQ:FBIO) Muted Revenues Despite A 99% Share Price Rise

There Is A Reason Fortress Biotech, Inc.'s (NASDAQ:FBIO) Price Is Undemanding

Aug 18
There Is A Reason Fortress Biotech, Inc.'s (NASDAQ:FBIO) Price Is Undemanding

Fortress to get NIH funding for trial of Triplex vaccine to prevent CMV in liver transplant patients

Aug 11

David Jin is the new finance chief of Fortress Biotech

Jul 22

Is Fortress Biotech (NASDAQ:FBIO) Using Debt Sensibly?

Jan 11
Is Fortress Biotech (NASDAQ:FBIO) Using Debt Sensibly?

Fortress Biotech (NASDAQ:FBIO) Has Debt But No Earnings; Should You Worry?

Sep 28
Fortress Biotech (NASDAQ:FBIO) Has Debt But No Earnings; Should You Worry?

Does Fortress Biotech (NASDAQ:FBIO) Have A Healthy Balance Sheet?

Jun 04
Does Fortress Biotech (NASDAQ:FBIO) Have A Healthy Balance Sheet?

Is Fortress Biotech (NASDAQ:FBIO) Using Too Much Debt?

Mar 04
Is Fortress Biotech (NASDAQ:FBIO) Using Too Much Debt?

When Will Fortress Biotech, Inc. (NASDAQ:FBIO) Turn A Profit?

Feb 06
When Will Fortress Biotech, Inc. (NASDAQ:FBIO) Turn A Profit?

Read This Before Buying Fortress Biotech, Inc. (NASDAQ:FBIO) Shares

Jan 11
Read This Before Buying Fortress Biotech, Inc. (NASDAQ:FBIO) Shares

Fortress Biotech founded Cyprium's CUTX-101 nabs accelerated review for copper metabolism disorder

Dec 15

Is Fortress Biotech, Inc. (NASDAQ:FBIO) Popular Amongst Insiders?

Dec 15
Is Fortress Biotech, Inc. (NASDAQ:FBIO) Popular Amongst Insiders?

Health Check: How Prudently Does Fortress Biotech (NASDAQ:FBIO) Use Debt?

Nov 19
Health Check: How Prudently Does Fortress Biotech (NASDAQ:FBIO) Use Debt?

Fortress Biotech EPS misses by $0.02, misses on revenue

Nov 09

Financial Position Analysis

Short Term Liabilities: FBIO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: FBIO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: FBIO has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: FBIO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FBIO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: FBIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 10.3% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.